In the US, Somatropin (somatropin systemic) is a member of the drug class growth hormones and is used to treat Adult Human Growth Hormone Deficiency, AIDS Related Wasting, Burns - Nitrogen Retention, Cachexia, Growth Retardation - Chronic Renal Failure, Hypopituitarism, Idiopathic Short Stature, Noonan's Syndrome, Pediatric Growth Hormone Deficiency, Short Bowel Syndrome, Short Stature for Age and Turner's Syndrome.
US matches:
- Somatropin (rDNA origin - Nonrefrigerated)
- Somatropin (rDNA origin - Refrigerated)
- Somatropin (rDNA origin - Refrigerated) Cartridge
- Somatropin (rDNA origin - Refrigerated) Vial
- Somatropin (rDNA origin - Refrigerated) Vials
- Somatropin
- Somatropin, e-coli derived Subcutaneous, Injection
- Somatropin, mammalian derived Subcutaneous, Injection
Ingredient matches for Somatropin
Somatropine
Somatropin (BAN, JAN, USAN) is also known as Somatropine (Rec.INN)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| JAN | Japanese Accepted Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment